Skip to main content
Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
9.52
-0.26 (-2.61%)
Dec 3, 2024, 1:58 PM EST - Market open

Ocular Therapeutix Revenue

Ocular Therapeutix had revenue of $15.43M in the quarter ending September 30, 2024, with 2.28% growth. This brings the company's revenue in the last twelve months to $61.44M, up 6.45% year-over-year. In the year 2023, Ocular Therapeutix had annual revenue of $58.44M with 13.49% growth.

Revenue (ttm)
$61.44M
Revenue Growth
+6.45%
P/S Ratio
21.84
Revenue / Employee
$230,120
Employees
267
Market Cap
1.50B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202358.44M6.95M13.49%
Dec 31, 202251.49M7.97M18.32%
Dec 31, 202143.52M26.12M150.08%
Dec 31, 202017.40M13.18M311.71%
Dec 31, 20194.23M2.24M112.41%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Guardian Pharmacy Services 1.17B
U.S. Physical Therapy 639.06M
BioCryst Pharmaceuticals 412.58M
Kiniksa Pharmaceuticals International, 384.10M
Harrow 169.14M
Arcutis Biotherapeutics 138.71M
Nurix Therapeutics 56.42M
Intellia Therapeutics 43.09M
Revenue Rankings

OCUL News

More News